Back

Biomarkers for early diagnosis of Takotsubo syndrome: a model development and validation study

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: New insights into imaging and biomarkers for diagnosis and prognosis of acute coronary syndromes Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Victor Schweiger

University Hospital Zurich, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail
Coronary CT angiography in acute coronary syndromes: a contemporary real-world experience
Doctor I. Chapman (Buenos Aires, AR)
Abstract
Presentation thumbnail
Coronary CT angiography in non-ST-segment elevation myocardial infarction
Ms S. Sandberg (Volda, NO)
Abstract
Presentation thumbnail
Intravascular imaging in patients with acute coronary syndromes: insights from the EuroHeart ACS-PCI registry collaboration
Doctor D. Bratu (Bucharest, RO)
Abstract
Presentation thumbnail
The diagnostic and prognostic value of growth stimulation expressed gene 2 in patients with coronary artery disease
Assistant Professor Y. Qu (Nanjing, CN)
Abstract

Access the full session

Session thumbnail
New insights into imaging and biomarkers for diagnosis and prognosis of acute coronary syndromes

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Novel scoring system for takotsubo syndrome
31 August 2019
thumbnail
Congress Presentation
Diagnostic and prognostic evaluation of novel biomarkers compared to esc 0/1-hour and 0/3-hour algorithms in patients with suspected non-ST-elevation myocardial infarction
21 March 2026
thumbnail
Congress Presentation
Plasma levels of cardiac-specific micro-RNA mir-1 and mir-133a differ in patients with acute myocardial infarction and takotsubo cardiomyopathy
2 September 2019
thumbnail
Congress Presentation
A 4-protein biomarker risk score enhances cardiovascular risk assessment: insights from the multi-ethnic study of atherosclerosis
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources